Laying the foundation stone for the BIOCEV centre












            ******************************************************************************************

            *
            ******************************************************************************************
            The 7 October saw the formal laying of the foundation stone for the BIOCEV centre in Veste

            This event represented the official start of the building process for the centre and was a
            Prime Minister, Jiří Rusnok. The nearly 25,500 m2 of new laboratories and other workspaces
            house around 600 employees, with 450 of these being scientific staff, including nearly two

            on master’s and doctorate programmes at the 1st Faculty of Medicine and the Faculty of Sci
            University. This October also sees the first anniversary of the start of BIOCEV’s first re
            ‘Functional Genomics’; further research programmes were started over the course of this ye

            The BIOCEV project is jointly realised by seven partner institutions, six research institu
            Czech Academy of Sciences (AS CR) and Charles University in Prague, represented by the 1st

            Medicine and the Faculty of Science. “We are delighted to be laying the foundation for suc
            and significant project. We are in no doubt that BIOCEV will be of massive benefit to the 
            science and the most significant project in the Czech Republic. The centre is well used by

            and doctorate programmes. We further anticipate that the BIOCEV centre will help us to fur
            experimental biotechnology and biomedicine,” said Václav Hampl, Rector of Charles Universi
            “It is precisely the cooperation between the Czech Academy of Sciences and Charles Univers

            main players in science and research in the Czech Republic, that is the guarantee of the s
            building of the BIOCEV centre. Furthermore, the major involvement of students in future re
            demonstration of the combination of research and teaching that is the basic prerequisite f

            education system,” emphasised Vladimír Mareček, Vice-Chairman of the AS CR, during the cer
            This October also sees the first anniversary of the start of BIOCEV’s first research progr
            Genomics’. Although the new centre in Vestec is still in the construction phase, scientist

            to begin research at their home institutions for the time being. The content of the Functi
            programme has attracted a number scientists to Prague from abroad, e.g. from Canada, Austr
            Germany, India, Bulgaria and Slovakia. During the first year of research, the Functional G

            and the associated national research infrastructure of the Czech Centre for Phenogenomics 
            in winning a European grant worth 10 million crowns. The funds gained are being used partl
            free access to technologies offered by CCP, e.g. the creation of transgenetic models of di

            archiving of mouse phyla, and partly for research into the causes of diseases such as meta
            congenital hearing loss and cardiovascular dysfunction, with the option of the proposal of
            gene therapy.

            Further research programmes were started over the course of this year. There are four such
            projects: Cellular Biology and Virology, Structural Biology and Protein Engineering, Bioma
            and Tissue Engineering and Development of Treatment and Diagnostic Methods. Around 280 emp

            currently working on all research programmes. The BIOCEV scientific programme is founded o
            synergies of all five research programmes. These joint research projects will help to dete
            illnesses such as liver disorders and various tumorous, neurological and immune diseases a

            personalisation and individualisation of treatment, which is the future of modern medicine
            of research in the field of biomaterials with stem-cell research can then lead to the cons
            tissue substitutes for e.g. heart valves and substitute blood vessels that are more accept

            organism, significantly reducing undesired side-effects of treatments administered followi